Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The complement membrane attack complex (MAC) is a multi-protein structure formed during the activation of the complement system. MAC assembles on the surface of target cells, forming transmembrane pores that disrupt cellular integrity, leading to cell lysis and death. While primarily known for its cytolytic function, sublytic MAC deposition can also trigger intracellular signaling pathways and induce proinflammatory responses. It represents a therapeutic target in various diseases, particularly those involving excessive complement activation or uncontrolled inflammation. Inhibiting MAC formation or function can be a strategy to mitigate tissue damage and disease progression.
Pore formation leading to cell lysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Membrane Attack Complex (MAC).